A Comparison of the Diagnostic Confidence and Image Quality Between the Eyoto Theia (RDSL) and a Predicate Device.
Completed
Conditions studied: Cataract
In brief
A clinical study has been identified as a requirement for the RDSL (Theia). This study involves a clinical comparison of the imaging from the RDSL with that of a predicate device. The clinical evaluation showed that there remains some residual risk in the practitioner's ability to use the imaging from the RDSL to detect pathologies at the same level as when using the imaging function on a predicate device. The aim of this comparative study is to determine the degree, if any, of difference in using images captured from the RDSL for clinical inspection of pathologies, when compared to images captured from a predicate device. Due to the involvement of real patients during the study, ethics approval was sought prior to commencement. This study is limited to the clinical benefits of the device. An additional Human factors study has been conducted to assess the useability of the device Images were taken of healthy eyes and eyes with pathology (with images of several pathologies from each major pathology group to give a full range) on both the predicate device, and the RDSL.
Key facts
- Study ID
- NCT05783583
- Run by
- Eyoto Group Ltd
- People needed
- 49
- Starts
- 2022-10-01
- Expected to finish
- 2023-01-20
- Last updated by the study team
- 2023-04-07
Who can join
Age: 21 and older, up to 99. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy eye or ocular pathology
You may not qualify if…
- No exclusion other than age as above
Where it is running
- National Vision Inc Corporate Office — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.